These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8687484)

  • 1. Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii.
    el Kouni MH; Naguib FN; Panzica RP; Otter BA; Chu SH; Gosselin G; Chu CK; Schinazi RF; Shealy YF; Goudgaon N; Ozerov AA; Ueda T; Iltzsch MH
    Biochem Pharmacol; 1996 Jun; 51(12):1687-700. PubMed ID: 8687484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
    el Kouni MH; Naguib FN; Chu SH; Cha SM; Ueda T; Gosselin G; Imbach JL; Shealy YF; Otter BA
    Mol Pharmacol; 1988 Aug; 34(2):104-10. PubMed ID: 3412318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
    Naguib FN; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1987 Jul; 36(13):2195-201. PubMed ID: 3606636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
    el Kouni MH; el Kouni MM; Naguib FN
    Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii.
    Iltzsch MH; Klenk EE
    Biochem Pharmacol; 1993 Nov; 46(10):1849-58. PubMed ID: 8250971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the 3'-OH group on the conformation and binding ability of anhydropyrimidine nucleosides to uridine phosphorylase.
    Veres Z; Neszmélyi A; Szabolcs A; Kiss AI; Dénes G
    Arch Biochem Biophys; 1991 Apr; 286(1):1-5. PubMed ID: 1897940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase.
    el Kouni MH; Goudgaon NM; Rafeeq M; Al Safarjalani ON; Schinazi RF; Naguib FN
    Biochem Pharmacol; 2000 Sep; 60(6):851-6. PubMed ID: 10930540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii.
    Iltzsch MH; Uber SS; Tankersley KO; el Kouni MH
    Biochem Pharmacol; 1995 May; 49(10):1501-12. PubMed ID: 7763293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
    Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
    Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of E. coli uridine phosphorylase. Further evidences of high-syn conformation of the substrate in uridine phosphorolysis.
    Alexeev CS; Sivets GG; Safonova TN; Mikhailov SN
    Nucleosides Nucleotides Nucleic Acids; 2017 Feb; 36(2):107-121. PubMed ID: 27846376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources.
    Drabikowska AK; Lissowska L; Veres Z; Shugar D
    Biochem Pharmacol; 1987 Dec; 36(23):4125-8. PubMed ID: 3318842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of uridine phosphorylase by pyrimidine nucleoside analogs and consideration of substrate binding to the enzyme based on solution conformation as seen by NMR spectroscopy.
    Veres Z; Neszmélyi A; Szabolcs A; Dénes G
    Eur J Biochem; 1988 Dec; 178(1):173-81. PubMed ID: 3203686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Substituted and 5,6-disubstituted derivatives of uridine: stereoselective synthesis, interaction with uridine phosphorylase, and in vitro antitumor activity.
    Felczak K; Drabikowska AK; Vilpo JA; Kulikowski T; Shugar D
    J Med Chem; 1996 Apr; 39(8):1720-8. PubMed ID: 8648611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uridine phosphorylase from Schistosoma mansoni.
    el Kouni MH; Naguib FN; Niedzwicki JG; Iltzsch MH; Cha S
    J Biol Chem; 1988 May; 263(13):6081-6. PubMed ID: 3360774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.
    Niedzwicki JG; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Substituted-2,2'-anhydrouridines, potent inhibitors of uridine phosphorylase.
    Veres Z; Szabolcs A; Szinai I; Dénes G; Kajtár-Peredy M; Otvös L
    Biochem Pharmacol; 1985 May; 34(10):1737-40. PubMed ID: 4004890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrimidine salvage pathways in Toxoplasma gondii.
    Iltzsch MH
    J Eukaryot Microbiol; 1993; 40(1):24-8. PubMed ID: 8457800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines.
    Bu W; Settembre EC; el Kouni MH; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):863-72. PubMed ID: 15983408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uridine phosphorylase from Hymenolepis diminuta (Cestoda): kinetics and inhibition by pyrimidine nucleoside analogs.
    Drabikowska AK
    Acta Biochim Pol; 1996; 43(4):733-41. PubMed ID: 9104511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of inhibitors of pyrimidine metabolism.
    Cha SM
    Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.